 
  WORLD TRADE  
ORGANIZATION  G/AG/W/64/Add.1 
17 September 2004 
 
 (04-3922) 
Committee on Agriculture Original:   English 
  
 
CHINA'S TRANSITIONAL REVIEW MECHANISM 
 
Addendum
 
 
Additional Questions to China from the United Stat es in the context of the Transitional Review 
Mechanism under Paragraph 18 of the Protocol of Accession of the People's Republic of China  
   The following communication, dated 16 September 2004, has been received from the 
Delegation of the United States, with the request that  it be circulated to Members, for the purposes of 
the Transitional Review to take place at the Committee's meeting on 23 September 2004. 
 
_______________ 
 
 AQSIQ Licensing for Inspection of Imports  
 On 30 August 2004, China issued a measure ex empting certain animal and plant products 
from entry quarantine review and approval, eff ective 1 September 2004.  The measure, General 
Administration of Quality Supervision, Insp ection and Quarantine (AQSIQ) Announcement 111, 
appears to exempt certain animal and plant products from the requirement to obtain a quarantine 
import inspection permit in adva nce of entry and prior to signing an import contract.  The 
United States welcomes China's modification of  its quarantine permit policies in Announcement 111 
to remove some products from the list of products  requiring quarantine permits, as traders have 
expressed continued concern regarding the burdensom e nature of the quarantine permit procedures.  
 
 (a) Announcement 111 lists the generic names of  certain products in the animal products 
and plant products categories that ar e exempted from the quarantine permit 
requirement, but does not provide sufficient detail for the trade or a description of these products based on Harmonized Schedule (HS) Number.  Please provide a description of exempted products by HS Number. 
 
 (b) Announcement 111 indicates that China's decision to exempt certain products is 
based on risk assessments.  Please provide  those risk assessments, along with any 
other analysis or criteria used as a basis for the exemptions. 
 
 (c) Were risk assessments performed on othe r products, i.e. products that are still on the 
list of products requiring quarantine perm its?  If so, please provide those risk 
assessments, along with any other analysis or criteria used. 
  
__________ 
 
 